Middle East & Africa Bacteriophages Therapy Market to 2032

Overview

The Middle East & Africa Bacteriophages Therapy Market is expected to reach a 1.25 USD Million by 2032 and is projected to grow at a CAGR of 6.47% from 2025 to 2032.

Revenue, 2024 (USD Million)

0.90

Forecast, 2032 (USD Million)

1.25

CAGR, 2024 - 2032

6.47%

Report Coverage

Middle East & Africa

Middle East & Africa Bacteriophages Therapy Market 2018-2032 USD Million

Middle East & Africa Bacteriophages Therapy Market, Key Findings (2025-2032)

Market Growth and Projections:

Market Size (2024): 0.90 USD Million
Projected Market Size (2032): 1.25 USD Million
CAGR (2025-2032): 6.47%

Key Findings of Middle East & Africa Bacteriophages Therapy Market

The Middle East & Africa Bacteriophages Therapy Market was valued at 0.90 USD Million in 2024.
The Middle East & Africa Bacteriophages Therapy Market is likely to grow at a CAGR of 6.47% during the forecast period of 2024 to 2032.
In 2024, the Largest segment Lytic in Type Segment accounted for the largest share of the market with a revenue of 0.82 USD Million
The fastest growing segment Supperative Skin Infections in Application Segment grew Fastest with a CAGR of 7.15% during the forecast period from 2024 to 2032.

Middle East & Africa Bacteriophages Therapy Market Scope

Middle East & Africa Bacteriophages Therapy Market Segmentation & Scope

End User

Others
Academic Research & Institutes
Speciality Clinics
Hospitals

Route Of Administration

Others
Parenteral
Dermal
Oral

Application

Lung And Pleural Infections
Supperative Skin Infections
Others
Bacterial Dysentery
Infections Of Skin And Nasal Mucosa
Postoperative Wound Infections

Base

Water-Soluble Jelly Base
Sterile Broth Culture

Type

Lysogenic
Lytic

Distribution Channel

Third Party Distributors
Direct Tender

Target

Salmonella
Streptococcus
Pseudomonas
Others
Escherichia coli
Staphylococcus

Middle East & Africa Bacteriophages Therapy Market Data Coverage Insights

Study Period	2024-2032
Base Year	2020
Unit	Revenue in USD Million
Market Value in 2024	0.90 USD Million
Market Value in 2032	1.25 USD Million
CAGR (2025-2032)	6.47%
Historic Data	2016-2023
Market Segments Covered	End User,Route Of Administration,Application,Base,Type,Distribution Channel,Target

Regional Insights:

Leading Market (2024-2032): Middle East & Africa, leading in terms of revenue 0.90 USD Million in 2024
- Key Country: South Africa, leading in terms of revenue with value of 0.42 USD Million in 2024.

Segments and Scope

Middle East & Africa Bacteriophages Therapy Market to 2032, By End User
- Hospitals is the largest segment in Middle East & Africa Bacteriophages Therapy Market to 2032 with a revenue of 0.34 USD Million in the year 2024.
- Speciality Clinics is the Fastest growing segment in Middle East & Africa Bacteriophages Therapy Market to 2032 with a Growth rate of 6.10 % in forecast period 2025-2032.
Middle East & Africa Bacteriophages Therapy Market to 2032, By Route Of Administration
- Oral is the largest segment in Middle East & Africa Bacteriophages Therapy Market to 2032 with a revenue of 0.39 USD Million in the year 2024.
- Dermal is the Fastest growing segment in Middle East & Africa Bacteriophages Therapy Market to 2032 with a Growth rate of 6.04 % in forecast period 2025-2032.
Middle East & Africa Bacteriophages Therapy Market to 2032, By Application
- Postoperative Wound Infections is the largest segment in Middle East & Africa Bacteriophages Therapy Market to 2032 with a revenue of 0.31 USD Million in the year 2024.
- Supperative Skin Infections is the Fastest growing segment in Middle East & Africa Bacteriophages Therapy Market to 2032 with a Growth rate of 6.88 % in forecast period 2025-2032.
Middle East & Africa Bacteriophages Therapy Market to 2032, By Base
- Sterile Broth Culture is the largest segment in Middle East & Africa Bacteriophages Therapy Market to 2032 with a revenue of 0.63 USD Million in the year 2024.
- Sterile Broth Culture is the Fastest growing segment in Middle East & Africa Bacteriophages Therapy Market to 2032 with a Growth rate of 6.68 % in forecast period 2025-2032.
Middle East & Africa Bacteriophages Therapy Market to 2032, By Type
- Lytic is the largest segment in Middle East & Africa Bacteriophages Therapy Market to 2032 with a revenue of 0.82 USD Million in the year 2024.
- Lytic is the Fastest growing segment in Middle East & Africa Bacteriophages Therapy Market to 2032 with a Growth rate of 6.55 % in forecast period 2025-2032.
Middle East & Africa Bacteriophages Therapy Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in Middle East & Africa Bacteriophages Therapy Market to 2032 with a revenue of 0.81 USD Million in the year 2024.
- Direct Tender is the Fastest growing segment in Middle East & Africa Bacteriophages Therapy Market to 2032 with a Growth rate of 6.55 % in forecast period 2025-2032.
Middle East & Africa Bacteriophages Therapy Market to 2032, By Target
- Staphylococcus is the largest segment in Middle East & Africa Bacteriophages Therapy Market to 2032 with a revenue of 0.25 USD Million in the year 2024.
- Escherichia coli is the Fastest growing segment in Middle East & Africa Bacteriophages Therapy Market to 2032 with a Growth rate of 6.10 % in forecast period 2025-2032.

Middle East & Africa Bacteriophages Therapy Market Company Share Analysis

Company Name
Microgen
MICREOS
Intralytix, Inc.
LOCUS BIOSCIENCES, INC.
Phagelux, Inc.

Middle East & Africa Bacteriophages Therapy Market Geographical Sales Distribution, 2018-2032 USD Million

Middle East & Africa Bacteriophages Therapy Market Company Profiling

Industry Related Reports

South America Cell And Gene Therapy Thawing Equipment Market

Middle East & Africa Cell And Gene Therapy Thawing Equipment Market

North America Cell And Gene Therapy Thawing Equipment Market

Europe Cell And Gene Therapy Thawing Equipment Market

Asia-Pacific Cell And Gene Therapy Thawing Equipment Market

Argentina Cell And Gene Therapy Thawing Equipment Market

Australia Cell And Gene Therapy Thawing Equipment Market

Belgium Cell And Gene Therapy Thawing Equipment Market

Brazil Cell And Gene Therapy Thawing Equipment Market

Canada Cell And Gene Therapy Thawing Equipment Market

Frequently Asked Questions

What are the primary segments covered in the Middle East & Africa Bacteriophages Therapy Market?

The Middle East & Africa Bacteriophages Therapy Market is segmented based on Segmentation End User,Route Of Administration,Application,Base,Type,Distribution Channel,Target.

What is the current market size of the Middle East & Africa Bacteriophages Therapy Market?

Middle East & Africa Bacteriophages Therapy Market was valued at USD 0.90(Revenue in USD Million) in 2020.

What is the expected growth rate of the Middle East & Africa Bacteriophages Therapy Market?

Middle East & Africa Bacteriophages Therapy Market is projected to grow at a CAGR of 6.47% during the forecast period of 2024 to 2032.

Which is the dominating segment in the Middle East & Africa Bacteriophages Therapy Market?

The Lytic segment is expected to dominate the Middle East & Africa Bacteriophages Therapy Market, holding a largest market share of 0.82 USD Million in 2024